Radiation Therapy

The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

RefleXion announces the installation of its RefleXion® X1 platform at Smilow Cancer Hospital, part of Yale New Haven Health. SCINTIX™ biology-guided radiotherapy, cleared by the FDA for treating tumors arising from primary or metastatic lung and bone cancers, will be installed as part of the integration. (Photo: Business Wire)

News | Radiation Oncology

RefleXion Announces Installation of X1 Platform at Smilow Cancer Hospital at Yale New Haven

March 3, 2023 — RefleXion Medical, Inc., a therapeutic oncology company, announced the installation of its RefleXion X1 ...

March 03, 2023

Elekta’s Comprehensive Motion Management (CMM) with True Tracking and automatic gating functionalities for Elekta Unity now available to clinicians in the U.S.

News | Radiation Therapy

Elekta Receives FDA 510(k) Clearance for Advanced Radiotherapy Motion Management Using Elekta Unity MR-Linac

February 28, 2023 — Elekta announced that Comprehensive Motion Management (CMM) with True Tracking and automatic gating ...

February 28, 2023

Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment

News | Brachytherapy Systems

Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT MD Surgical Guidance System

February 23, 2023 — Merit Medical Systems, Inc., a leading global manufacturer and marketer of healthcare technology ...

February 23, 2023

Derry Crighton, one of the first patients to be treated last week with the new Elekta Esprit, a Leksell Gamma Knife stereotactic radiosurgery (SRS) system, at the National Centre for Stereotactic Radiosurgery in Sheffield, UK

News | Radiation Oncology

First Gamma Knife Esprit Patient Resumes Life as Usual Only Days After Brain Surgery

February 17, 2023 — Derry Crighton, a father of three from Scotland, says the Elekta Esprit radiosurgery system used to ...

February 17, 2023

Patients underwent BNCT using TAE Life Sciences’ Neutron Beam System as part of Neuboron Medical Group’s NeuPex System at Xiamen Humanity Hospital in China

News | Radiation Therapy

TAE Life Sciences Announces First Cancer Patient Treatments Using Accelerator-Based Biologically Targeted Radiation Therapy (BNCT)

February 16, 2023 — TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation ...

February 16, 2023

Under the theme ‘Together, we can eliminate cervical cancer’, participants shared new evidence and best practices.

News | Radiation Oncology

Elekta Foundation’s Cancer Care Successes in Rwanda to be Expanded in Other Low-income Countries

February 7, 2023 — During World Cancer Day (February 4), the Elekta Foundation celebrated its first year by highlighting ...

February 07, 2023

Moffitt study shows this approach is effective for this rare tumor

News | Radiation Oncology

Stereotactic Body Radiotherapy Is an Effective Treatment for Patients with Lung Neuroendocrine Tumors

February 7, 2023 — Primary lung neuroendocrine tumors are very rare tumors that represent about 1-2% of all lung cancer ...

February 07, 2023

Moffitt Cancer Center at International Plaza

News | Proton Therapy

IBA Announces Contract with Moffitt Cancer Center for a Proteus ONE Proton Therapy Solution

February 7, 2023 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology, today announces ...

February 07, 2023

Achieves CE mark for Halcyon and Ethos radiotherapy systems featuring HyperSight

News | Radiation Therapy

Varian Receives FDA 510(k) Clearance for Halcyon and Ethos Radiotherapy Systems Featuring HyperSight Imaging Solution

February 6, 2023 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

February 06, 2023

Third Research Study from DenseBreast-info.org Shows Knowledge Gaps among Healthcare Providers about Breast Cancer Risk Models and High-Risk Screening Recommendations

News | Radiation Therapy

Health Care Provider Knowledge Gaps on Breast Cancer Risk Must be Resolved to Improve Screening

February 2, 2023 — DenseBreast-info.org (DBI) announced the results of the study, “Effect of an Educational Intervention ...

February 02, 2023

RefleXion's co-founder and CTO, Sam Mazin, Ph.D. and Todd Powell, CEO and president. (Photo: Business Wire)

News | Radiation Therapy

RefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy

February 2, 2023 — RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug ...

February 02, 2023

software for the treatment of cancer with radiotherapy

News | Radiation Therapy

Brazilian Startup Pioneers Cloud Software for Secondary Monitor Unit Calculation in Radiotherapy, Enhancing Patient Safety

February 1, 2023 — Radiotherapy is a crucial component of cancer treatment, used to shrink or destroy tumors with high ...

February 01, 2023

Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records.

News | Radiation Therapy

Study Finds Large Gap in Breast Cancer Treatment Recommendations for Patients Aged 70 vs 69

January 31, 2023 — Age-based heuristics can lead to large differences in breast cancer treatment based on small ...

January 31, 2023

The Cancer Breakthroughs session of ASTRO2022 included research findings presented on behalf of the American Society of Clinical Oncology (ASCO) and the American Association of Physicists in Medicine (AAPM). Photo credit: ASTRO

Feature | ASTRO | Christine Book

ASTRO 2022 Shines Spotlight on “Cancer Breakthroughs” with AAPM, ASCO Research

The Imaging Technology News (ITN) editorial team is pleased to present the second portion of the American Society for ...

January 13, 2023

The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James)

News | Proton Therapy

Leading U.S. Cancer Center Selects RayStation for Proton Planning

January 13, 2023 — RaySearch Laboratories AB announces that The Ohio State University Comprehensive Cancer Center - ...

January 13, 2023

RaySearch Laboratories AB announced that CGN Medical Technologies has in December 2002 placed an order for RayStation, which CGN has sold together with IBA’s proton therapy system to Yangzhou Hospital in China.

News | Proton Therapy

CGN Selects RayStation for Yangzhou Hospital

January 9, 2023 — RaySearch Laboratories AB announced that CGN Medical Technologies has in December 2002 placed an order ...

January 08, 2023

Feature | Radiology Business | By Melinda Taschetta-Millane

ITN's Top 20 from 2022

As 2022 comes to a close, the Imaging Technology News team takes a look at the year's most viewed content. Here is a ...

January 02, 2023

IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract with the Spanish Ministry of Health to install ten proton therapy systems across Spain as part of a significant public tender.

News | Proton Therapy

IBA Wins 10 Proton Therapy System Contract in Spain

January 2, 2023 — IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract ...

January 02, 2023

New technology expected to drive efficiency with condensed treatment courses, fewer side effects, and improved outcomes for people with cancer

News | Linear Accelerators

First Ever Patient Treated for Pancreatic Cancer Using Elekta Unity MR-Linac

December 30, 2022 — A milestone was reached in radiation therapy last week as the first patients completed their full ...

December 30, 2022

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines — such as doxorubicin, frequently used against breast cancer — kill cancer cells by damaging their DNA. However, these effective chemotherapies also cause toxic effects in the heart in about ten percent of patients that can eventually lead to heart failure, particularly in older patients with pre-existing cardiovascular disease. Current

News | Breast Imaging

Researchers ID Protein that may Protect the Heart During Certain Cancer Treatment Regimens

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including ...

December 29, 2022